Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

Early Prediction of Response to INP104 for the Acute Treatment of Migraine

Presented at the AAN Annual Meeting, April 2-7, 2022 Authors: Sara Sacco, Robert Vann, Sutapa Ray, Stephen B. Shrewsbury, Sheena K. Aurora Objective: This post hoc analysis aimed to determine if early treatment response to INP104 could predict response over consecutive migraine attacks (MAs).…

Improvements in Disability and the Interictal Period with INP104: Results from the Phase 3 STOP 301 Study

Poster presented at the 15th Annual HCOP Winter Conference; Ojai, CA; January 28-29, 2022 Authors: Dawn C. Buse, PhD; Cynthia E. Armand, MD; Rob Vann, PhD; Sutapa Ray, PhD; Michelle Murphy, PhD; Stephen B. Shrewsbury, MB ChB; Sheena K. Aurora,…

Recurrence Rates for INP104 for the Acute Treatment of Migraine: Results from the Phase 3 STOP 301 Open-Label Study

Poster presented at the 15th Annual HCOP Winter Conference; Ojai, CA; January 28-29, 2022 Authors: Stewart J. Tepper, MD, Jessica Ailani, MD, TinaMarie Lieu, PhD, Sheena K. Aurora, MD, Stephen B. Shrewsbury, MB ChB Introduction: Recurrence of migraine headache is…

2 3 4